|
Delayed
London S.E.
04:02:40 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.1610 GBX | +0.62% |
|
+0.62% | -51.94% |
| 10/08 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 10/08 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
Chart: Technical Analysis
Stock exchange
London S.E.
VAL 0.1610 p
+0.62%
2L
p
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
London S.E.
| VAL | 0.1610GBX | +0.62% | 2L p | |
Deutsche Boerse AG
| EAJF | 0.000500EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| EAJF | 0.001500EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 0.17 | 0.225 | 0.335 |
| Spread/Res. | -5.29% | -28.44% | -51.94% |
| Spread/Supp. | +11.03% | +11.03% | +11.03% |
| Support | 0.145 | 0.145 | 0.145 |
- Stock Market
- Stocks
- VAL Stock
- Charts ValiRx plc
Select your edition
All financial news and data tailored to specific country editions
